amantadine has been researched along with Appetite Disorders in 5 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amantadine was reported to decrease serum alanine aminotransferase and HCV RNA levels in chronic hepatitis C patients who had not respond to interferon, but further experience has produced mixed results." | 9.09 | Treatment of chronic hepatitis C patients with amantadine. ( Harada, H; Yagura, M, 2001) |
| "Amantadine hydrochloride (Symmetrel), an antiviral, antiparkinson agent that is most frequently used clinically at oral doses of 2 to 3 mg/kg, significantly decreased d-amphetamine-induced CNS stimulation (motor activity) and simultaneously increased d-amphetamine-induced anorexia (milk intake) in mice." | 7.65 | Amantadine decreases d-amphetamine stimulation and increases d-amphetamine anorexia in mice. ( Clark, R; Rubin, AA; Smith, DH; Vernier, VG, 1976) |
| "Amantadine was reported to decrease serum alanine aminotransferase and HCV RNA levels in chronic hepatitis C patients who had not respond to interferon, but further experience has produced mixed results." | 5.09 | Treatment of chronic hepatitis C patients with amantadine. ( Harada, H; Yagura, M, 2001) |
| "Amantadine hydrochloride (Symmetrel), an antiviral, antiparkinson agent that is most frequently used clinically at oral doses of 2 to 3 mg/kg, significantly decreased d-amphetamine-induced CNS stimulation (motor activity) and simultaneously increased d-amphetamine-induced anorexia (milk intake) in mice." | 3.65 | Amantadine decreases d-amphetamine stimulation and increases d-amphetamine anorexia in mice. ( Clark, R; Rubin, AA; Smith, DH; Vernier, VG, 1976) |
| "Five patients with Parkinson's disease, when first seen, manifested an abnormal increase in appetite." | 1.26 | Increased appetite (bulimia) in Parkinson's disease. ( Beilin, B; Herishanu, Y; Rosenberg, P, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yagura, M | 1 |
| Harada, H | 1 |
| Rosenberg, P | 1 |
| Herishanu, Y | 1 |
| Beilin, B | 1 |
| Clark, R | 1 |
| Smith, DH | 1 |
| Vernier, VG | 1 |
| Rubin, AA | 1 |
| Papeschi, R | 1 |
1 review available for amantadine and Appetite Disorders
| Article | Year |
|---|---|
Use of drugs in the treatment of parkinsonism.
Topics: Amantadine; Depression; Dihydroxyphenylalanine; Feeding and Eating Disorders; Humans; Hypertension; | 1970 |
1 trial available for amantadine and Appetite Disorders
| Article | Year |
|---|---|
Treatment of chronic hepatitis C patients with amantadine.
Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Amantadine; Antiviral Agents; Cataract; Cognit | 2001 |
3 other studies available for amantadine and Appetite Disorders
| Article | Year |
|---|---|
Increased appetite (bulimia) in Parkinson's disease.
Topics: Aged; Amantadine; Feeding and Eating Disorders; Female; Humans; Hunger; Levodopa; Male; Middle Aged; | 1977 |
Amantadine decreases d-amphetamine stimulation and increases d-amphetamine anorexia in mice.
Topics: Amantadine; Animals; Anorexia; Dextroamphetamine; Drug Interactions; Feeding and Eating Disorders; F | 1976 |
Amantadine may stimulate dopamine and noradrenaline receptors.
Topics: Amantadine; Animals; Behavior, Animal; Body Temperature; Brain; Catalepsy; Catecholamines; Dopamine; | 1974 |